Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factors II (prothrombin), IX, and X are essential vitamin K-dependent serine proteases in the blood coagulation cascade. Factor II (prothrombin) is cleaved to form thrombin (factor IIa), which plays a pivotal role in converting fibrinogen to fibrin and activating additional coagulation factors[3][4]. Factor IX is a key enzyme of the intrinsic pathway; when activated (FIXa), it complexes with factor VIIIa to convert factor X to Xa[1][3][4][7]. Factor X, once activated (FXa), forms part of the prothrombinase complex, catalyzing prothrombin activation to thrombin, leading to fibrin clot formation[3][4]. They are structurally characterized by an N-terminal Gla domain, two epidermal growth factor-like domains, and a serine protease domain (prothrombin includes kringle domains instead of EGF-like domains)[3]. These factors are primary targets for multiple classes of anticoagulants and are critical both as diagnostic markers and as therapeutic agents in bleeding and clotting disorders.
Inhibition of factor activity (e.g., direct inhibition of FXa or thrombin; vitamin K antagonism), replacement therapy, reversal of anticoagulation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation factors II, IX, X (FII, FIX, FX).